Related Experiment Video
Updated: May 5, 2026

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
5.5K
Diabetes "Trade Journals": A Rather Heterogeneous Affair
1Science Consulting in Diabetes GmbH, Düsseldorf, Germany.
Journal of Diabetes Science and Technology
|December 1, 2025
Summary
Many diabetes journals exist, but some lack impact and rigorous review. Authors should critically evaluate journals, especially those promising rapid publication and charging fees, to avoid predatory practices.
Area of Science:
- Medical Journalism
- Scholarly Publishing
- Diabetes Research
Background:
- A wide array of medical journals cater to diabetes research.
- However, only a fraction are indexed in prominent databases like PubMed.
- Numerous other journals solicit manuscripts, promising expedited publication.
Purpose of the Study:
- To critically assess the impact and review process of certain diabetes journals.
- To investigate the business models and publication fees of these journals.
- To raise awareness about potential issues such as non-publication after fee payment and questionable quality.
Main Methods:
- Qualitative analysis of journal solicitation practices.
- Critical review of journal indexing and impact metrics.
- Examination of reported publication fees and author experiences (implied).
Main Results:
- Many diabetes journals are not indexed in major databases.
- Journals offering rapid publication may have questionable review standards and impact.
- Concerns exist regarding transparency of business models, publication fees, and actual manuscript publication.
Conclusions:
- Authors must exercise caution when submitting to journals, particularly those with aggressive solicitation and high fees.
- The quality and legitimacy of some diabetes journals warrant scrutiny.
- Further investigation into the practices of non-indexed journals is needed.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Introduction
56
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
56
Hypoglycemia
34
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
34

